It's the thorny challenges to reopening the European Union's internal borders that show just how tricky living with COVID-19 really is.
For Lionel Laurent's latest contributions to The Japan Times, see below:
A rush to publish studies based on flawed science gets us no closer to a cure, and hurts public trust.
Fears of a flare-up in virus cases after lockdown haven’t come to pass, though some caution is warranted.
“Buyer beware” isn’t enough when it comes to antibody tests, where small errors can have huge consequences.
The country's lockdown model is being lauded by the WHO, but it's a unique case whose death rate is much worse than its neighbors.
Sometimes a coronavirus death count can be much bigger than it initially appears.
This has been a crisis of health-care cooperation, not cash.
Ending strict confinement measures should be done extremely carefully.
Carlos Ghosn's dramatic escape reopens old wounds and shows how tough it is to keep two politically-sensitive and financially lop-sided carmakers together.
As regulators wake up to the threat of this technology, governments are pushing back with an unconvincing public-safety defense